Neuroprotective Effects of Celastrol in Neurodegenerative Diseases-Unscramble Its Major Mechanisms of Action and Targets

Overview

Journal Aging Dis

Specialty Geriatrics

Date 2022 Jun 3

PMID 35656110

Authors

Dandan Liu

Qian Zhang

Piao Luo

Liwei Gu

Shengnan Shen

Huan Tang

Ying Zhang

Ming Lyu

Qiaoli Shi

Chuanbin Yang

Jigang Wang

Affiliations

Soon will be listed here.

Abstract

There are rarely new therapeutic breakthroughs present for neurodegenerative diseases in the last decades. Thus, new effective drugs are urgently needed for millions of patients with neurodegenerative diseases. Celastrol, a pentacyclic triterpenoid compound, is one of the main active ingredients isolated from Hook. f. that has multiple biological activities. Recently, amount evidence indicates that celastrol exerts neuroprotective effects and holds therapeutic potential to serve as a novel agent for neurodegenerative diseases. This review focuses on the therapeutic efficacy and major regulatory mechanisms of celastrol to rescue damaged neurons, restore normal cognitive and sensory motor functions in neurodegenerative diseases. Importantly, we highlight recent progress regarding identification of the drug targets of celastrol by using advanced quantitative chemical proteomics technology. Overall, this review provides novel insights into the pharmacological activities and therapeutic potential of celastrol for incurable neurodegenerative diseases.

Citing Articles

Anti-Inflammatory, Antibacterial, Anti-Biofilm, and Anti-Quorum Sensing Activities of the Diterpenes Isolated from .

Apaza Ticona L, Martinez Nogueron A, Sanchez Sanchez-Corral J, Montoto Lozano N, Ortega Domenech M Pharmaceutics. 2024; 16(8).

PMID: 39204439 PMC: 11360483. DOI: 10.3390/pharmaceutics16081094.

Celastrol ameliorates hypoxic-ischemic brain injury in neonatal rats by reducing oxidative stress and inflammation.

Hu Y, Nan Y, Lin H, Zhao Q, Chen T, Tao X Pediatr Res. 2024; 96(7):1681-1692.

PMID: 38763946 PMC: 11772252. DOI: 10.1038/s41390-024-03246-9.

Celastrol Pyrazine Derivative Alleviates Silicosis Progression via Inducing ROS-Mediated Apoptosis in Activated Fibroblasts.

Bai Y, Liang C, Gao L, Han T, Wang F, Liu Y Molecules. 2024; 29(2).

PMID: 38276616 PMC: 10820882. DOI: 10.3390/molecules29020538.

Withaferin A and Celastrol Overwhelm Proteostasis.

Vilaboa N, Voellmy R Int J Mol Sci. 2024; 25(1).

PMID: 38203539 PMC: 10779417. DOI: 10.3390/ijms25010367.

A comprehensive review of hook. f. in the treatment of rheumatic and autoimmune diseases: Bioactive compounds, mechanisms of action, and future directions.

Shan Y, Zhao J, Wei K, Jiang P, Xu L, Chang C Front Pharmacol. 2023; 14:1282610.

PMID: 38027004 PMC: 10646552. DOI: 10.3389/fphar.2023.1282610.

References

Nakamichi K, Kitani H, Takayama-Ito M, Morimoto K, Kurane I, Saijo M . Celastrol suppresses morphological and transcriptional responses in microglial cells upon stimulation with double-stranded RNA. Int J Neurosci. 2010; 120(4):252-7. DOI: 10.3109/00207451003615763. View

Lu C, Zhang X, Zhang D, Pei E, Xu J, Tang T . Short time tripterine treatment enhances endothelial progenitor cell function via heat shock protein 32. J Cell Physiol. 2014; 230(5):1139-47. DOI: 10.1002/jcp.24849. View

Nakazono A, Adachi N, Takahashi H, Seki T, Hamada D, Ueyama T . Pharmacological induction of heat shock proteins ameliorates toxicity of mutant PKCγ in spinocerebellar ataxia type 14. J Biol Chem. 2018; 293(38):14758-14774. PMC: 6153279. DOI: 10.1074/jbc.RA118.002913. View

Zhang X, Zhao W, Liu X, Huang Z, Shan R, Huang C . Celastrol ameliorates inflammatory pain and modulates HMGB1/NF-κB signaling pathway in dorsal root ganglion. Neurosci Lett. 2018; 692:83-89. DOI: 10.1016/j.neulet.2018.11.002. View

Yang H, Wang H, Andersson U . Targeting Inflammation Driven by HMGB1. Front Immunol. 2020; 11:484. PMC: 7099994. DOI: 10.3389/fimmu.2020.00484. View

Dai W, Wang X, Teng H, Li C, Wang B, Wang J . Celastrol inhibits microglial pyroptosis and attenuates inflammatory reaction in acute spinal cord injury rats. Int Immunopharmacol. 2018; 66:215-223. DOI: 10.1016/j.intimp.2018.11.029. View

Sahu I, Sangith N, Ramteke M, Gadre R, Venkatraman P . A novel role for the proteasomal chaperone PSMD9 and hnRNPA1 in enhancing IκBα degradation and NF-κB activation - functional relevance of predicted PDZ domain-motif interaction. FEBS J. 2014; 281(11):2688-709. DOI: 10.1111/febs.12814. View

Xu H, Cai Y, Yu M, Sun J, Cai J, Li J . Celastrol protects against early brain injury after subarachnoid hemorrhage in rats through alleviating blood-brain barrier disruption and blocking necroptosis. Aging (Albany NY). 2021; 13(12):16816-16833. PMC: 8266331. DOI: 10.18632/aging.203221. View

Ye F, Garton H, Hua Y, Keep R, Xi G . The Role of Thrombin in Brain Injury After Hemorrhagic and Ischemic Stroke. Transl Stroke Res. 2020; 12(3):496-511. PMC: 8005504. DOI: 10.1007/s12975-020-00855-4. View

10.

Liu M, Chen M, Luo Y, Wang H, Huang H, Peng Z . Lipidomic Profiling of Ipsilateral Brain and Plasma after Celastrol Post-Treatment in Transient Middle Cerebral Artery Occlusion Mice Model. Molecules. 2021; 26(14). PMC: 8306490. DOI: 10.3390/molecules26144124. View

11.

Sreeramulu S, Gande S, Gobel M, Schwalbe H . Molecular mechanism of inhibition of the human protein complex Hsp90-Cdc37, a kinome chaperone-cochaperone, by triterpene celastrol. Angew Chem Int Ed Engl. 2009; 48(32):5853-5. DOI: 10.1002/anie.200900929. View

12.

Beijer D, Kim H, Guo L, ODonovan K, Mademan I, Deconinck T . Characterization of HNRNPA1 mutations defines diversity in pathogenic mechanisms and clinical presentation. JCI Insight. 2021; 6(14). PMC: 8410042. DOI: 10.1172/jci.insight.148363. View

13.

Kahl A, Blanco I, Jackman K, Baskar J, Mohan H, Rodney-Sandy R . Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Sci Rep. 2018; 8(1):2701. PMC: 5807442. DOI: 10.1038/s41598-018-21063-z. View

14.

Kalmar B, Greensmith L . Activation of the heat shock response in a primary cellular model of motoneuron neurodegeneration-evidence for neuroprotective and neurotoxic effects. Cell Mol Biol Lett. 2009; 14(2):319-35. PMC: 6275696. DOI: 10.2478/s11658-009-0002-8. View

15.

Tang Y, Le W . Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2015; 53(2):1181-1194. DOI: 10.1007/s12035-014-9070-5. View

16.

Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L . The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biol. 2021; 47:102134. PMC: 8487081. DOI: 10.1016/j.redox.2021.102134. View

17.

Popichak K, Hammond S, Moreno J, Afzali M, Backos D, Slayden R . Compensatory Expression of Nur77 and Nurr1 Regulates NF-B-Dependent Inflammatory Signaling in Astrocytes. Mol Pharmacol. 2018; 94(4):1174-1186. PMC: 6117504. DOI: 10.1124/mol.118.112631. View

18.

Li J, Hao J . Treatment of Neurodegenerative Diseases with Bioactive Components of . Am J Chin Med. 2019; 47(4):769-785. DOI: 10.1142/S0192415X1950040X. View

19.

Hu M, Luo Q, Alitongbieke G, Chong S, Xu C, Xie L . Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy. Mol Cell. 2017; 66(1):141-153.e6. PMC: 5761061. DOI: 10.1016/j.molcel.2017.03.008. View

20.

Yuan Y, Gu Z, Shi Q, Qin G, Xu R, Cao L . [In vitro inhibition of celastrol on spermatozoa fertilization ability of guinea pig]. Yao Xue Xue Bao. 1995; 30(5):331-5. View